Sign Up
OverviewAPI
USITC report delves into patent rules' impact on COVID-19 diagnostics, with concerns about U.S. companies losing IP protections. The article also discusses the high costs of gene therapy for Sickle Cell Disease and the need for a regulatory process that enhances treatment options for immunocompromised individuals.

Ask a question